rss
J Med Ethics 2006;32:143-147 doi:10.1136/jme.2004.010272
  • Clinical ethics

Ethical issues in predictive genetic testing: a public health perspective

  1. K G Fulda1,
  2. K Lykens2
  1. 1Department of Biostatistics, School of Public Health, University of North Texas Health Science Center, Fort Worth, USA
  2. 2Department of Health Management and Policy, School of Public Health, University of North Texas Health Science Center, Fort Worth, USA
  1. Correspondence to:
 Kimberly Fulda
 MPH at 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA; kfulda{at}hsc.unt.edu
  • Received 6 August 2004
  • Accepted 25 May 2005
  • Revised 5 May 2005

Abstract

As a result of the increase in genetic testing and the fear of discrimination by insurance companies, employers, and society as a result of genetic testing, the disciplines of ethics, public health, and genetics have converged. Whether relatives of someone with a positive predictive genetic test should be notified of the results and risks is a matter urgently in need of debate. Such a debate must encompass the moral and ethical obligations of the diagnosing physician and the patient. The decision to inform or not will vary depending on what moral theory is used. Utilising the utilitarian and libertarian theories produces different outcomes. The principles of justice and non-maleficence will also play an important role in the decision.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.